These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26799588)

  • 1. Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer.
    Pucci S; Zonetti MJ; Fisco T; Polidoro C; Bocchinfuso G; Palleschi A; Novelli G; Spagnoli LG; Mazzarelli P
    Oncotarget; 2016 Apr; 7(15):19982-96. PubMed ID: 26799588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation?
    Mazzarelli P; Pucci S; Bonanno E; Sesti F; Calvani M; Spagnoli LG
    Cancer Biol Ther; 2007 Oct; 6(10):1606-13. PubMed ID: 18253084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
    Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
    Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
    Linher-Melville K; Zantinge S; Sanli T; Gerstein H; Tsakiridis T; Singh G
    BMC Cancer; 2011 Feb; 11():56. PubMed ID: 21294903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer.
    Wang L; Li C; Song Y; Yan Z
    Arch Biochem Biophys; 2020 Dec; 696():108664. PubMed ID: 33157102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
    Aiderus A; Black MA; Dunbier AK
    BMC Cancer; 2018 Aug; 18(1):805. PubMed ID: 30092766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.
    Xiong Y; Liu Z; Zhao X; Ruan S; Zhang X; Wang S; Huang T
    Biomed Pharmacother; 2018 Oct; 106():1-7. PubMed ID: 29940537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting fatty acid oxidation enhances response to HER2-targeted therapy.
    Nandi I; Ji L; Smith HW; Avizonis D; Papavasiliou V; Lavoie C; Pacis A; Attalla S; Sanguin-Gendreau V; Muller WJ
    Nat Commun; 2024 Aug; 15(1):6587. PubMed ID: 39097623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non‑coding RNA nuclear paraspeckle assembly transcript 1 interacts with microRNA‑107 to modulate breast cancer growth and metastasis by targeting carnitine palmitoyltransferase‑1.
    Xiong Y; Liu Z; Li Z; Wang S; Shen N; Xin Y; Huang T
    Int J Oncol; 2019 Nov; 55(5):1125-1136. PubMed ID: 31485672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.
    Tan Z; Zou Y; Zhu M; Luo Z; Wu T; Zheng C; Xie A; Wang H; Fang S; Liu S; Li Y; Lu Z
    BMC Cancer; 2021 Apr; 21(1):409. PubMed ID: 33858374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CPT1A enhances metabolic therapy in human melanoma cells with the BRAF V600E mutation.
    Sung GJ; Choi HK; Kwak S; Song JH; Ko H; Yoon HG; Kang HB; Choi KC
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):76-81. PubMed ID: 27793752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.
    Shi J; Fu H; Jia Z; He K; Fu L; Wang W
    EBioMedicine; 2016 Dec; 14():55-64. PubMed ID: 27916548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine.
    Shin ES; Cho SY; Lee EH; Lee SJ; Chang IS; Lee TR
    Eur J Nutr; 2006 Mar; 45(3):159-64. PubMed ID: 16362726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential.
    Schlaepfer IR; Joshi M
    Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31900483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
    Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
    Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnitine palmitoyltransferase 1A prevents fatty acid-induced adipocyte dysfunction through suppression of c-Jun N-terminal kinase.
    Gao X; Li K; Hui X; Kong X; Sweeney G; Wang Y; Xu A; Teng M; Liu P; Wu D
    Biochem J; 2011 May; 435(3):723-32. PubMed ID: 21348853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid β-oxidation promotes breast cancer stemness and metastasis via the miRNA-328-3p-CPT1A pathway.
    Zeng F; Yao M; Wang Y; Zheng W; Liu S; Hou Z; Cheng X; Sun S; Li T; Zhao H; Luo Y; Li J
    Cancer Gene Ther; 2022 Mar; 29(3-4):383-395. PubMed ID: 34045663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine palmitoyl transferase I: Conformational changes induced by long-chain fatty acyl CoA ligands.
    Lopes VG; Filho ABC; Yoshinaga MY; Hirata MH; Ferreira GM
    J Mol Graph Model; 2022 May; 112():108125. PubMed ID: 35101729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine-acyltransferase system inhibition, cancer cell death, and prevention of myc-induced lymphomagenesis.
    Pacilli A; Calienni M; Margarucci S; D'Apolito M; Petillo O; Rocchi L; Pasquinelli G; Nicolai R; Koverech A; Calvani M; Peluso G; Montanaro L
    J Natl Cancer Inst; 2013 Apr; 105(7):489-98. PubMed ID: 23486551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approach.
    Das M; Giannoudis A; Sharma V
    Sci Rep; 2022 Sep; 12(1):16441. PubMed ID: 36180554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.